A Study of Auxora in Patients With AKI and Injurious Lung "Crosstalk"

Summary

Approximately 150 patients with acute kidney injury (AKI) associated with acute hypoxemic respiratory failure (AHRF) will be randomized at up to 40 sites. Patients will be randomly assigned to either Auxora or matching placebo. Study drug infusions will occur every 24 hours for five consecutive days for a total of five infusions.

Timeline

Start

2024-07-01

Primary completion

2026-07

Completion

2026-07

Drugs

Indications